Cole K, Al-Kadhimi Z, Talmadge J
Int Immunopharmacol. 2023; 117:109882.
PMID: 36848790
PMC: 10355273.
DOI: 10.1016/j.intimp.2023.109882.
McCarthy C, Carey B, Trapnell B
Am J Respir Crit Care Med. 2022; 205(9):1016-1035.
PMID: 35227171
PMC: 9851473.
DOI: 10.1164/rccm.202112-2742SO.
Chu Y, Nayyar G, Su N, Rosenblum J, Soon-Shiong P, Lee J
J Immunother Cancer. 2020; 8(2).
PMID: 33109629
PMC: 7592258.
DOI: 10.1136/jitc-2020-001238.
Dillman R
Melanoma Manag. 2020; 7(3):MMT49.
PMID: 32922731
PMC: 7475793.
DOI: 10.2217/mmt-2020-0011.
Ji J, Lee J, Choi J, Choi Y, Kim E, Chu S
Toxicol Res. 2020; 24(4):315-320.
PMID: 32038810
PMC: 7006265.
DOI: 10.5487/TR.2008.24.4.315.
Analysis of hidradenitis suppurativa-linked mutations in four genes and the effects of PSEN1-P242LfsX11 on cytokine and chemokine expression in macrophages.
Li A, Peng Y, Taiclet L, Tanzi R
Hum Mol Genet. 2018; 28(7):1173-1182.
PMID: 30544224
PMC: 6423421.
DOI: 10.1093/hmg/ddy414.
Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.
Palle P, Monaghan K, Milne S, Wan E
Med Sci (Basel). 2017; 5(4).
PMID: 29099039
PMC: 5753652.
DOI: 10.3390/medsci5040023.
Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.
Grant S, Heel R
Drugs. 2017; 43(4):516-560.
PMID: 28421558
DOI: 10.2165/00003495-199243040-00008.
Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-mediated delivery in cancer immunotherapy.
Vanitha S, Chaubey N, Ghosh S, Sanpui P
Bioengineered. 2016; 8(2):120-123.
PMID: 27459024
PMC: 5398574.
DOI: 10.1080/21655979.2016.1212136.
Delivery of GM-CSF to Protect against Influenza Pneumonia.
Subramaniam R, Hillberry Z, Chen H, Feng Y, Fletcher K, Neuenschwander P
PLoS One. 2015; 10(4):e0124593.
PMID: 25923215
PMC: 4414562.
DOI: 10.1371/journal.pone.0124593.
Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.
Spitler L, Cao H, Piironen T, Whiteside T, Weber R, Cruickshank S
Am J Clin Oncol. 2014; 40(2):207-213.
PMID: 25286079
PMC: 4385005.
DOI: 10.1097/COC.0000000000000124.
The colony-stimulating factors and cancer.
Metcalf D
Nat Rev Cancer. 2010; 10(6):425-34.
PMID: 20495576
PMC: 3345291.
DOI: 10.1038/nrc2843.
Biologically active human GM-CSF produced in the seeds of transgenic rice plants.
Sardana R, Dudani A, Tackaberry E, Alli Z, Porter S, Rowlandson K
Transgenic Res. 2007; 16(6):713-21.
PMID: 17985214
DOI: 10.1007/s11248-006-9062-y.
Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets.
Ganguly D, Paul K, Bagchi J, Rakshit S, Mandal L, Bandyopadhyay G
Immunology. 2007; 121(4):499-507.
PMID: 17433076
PMC: 2265964.
DOI: 10.1111/j.1365-2567.2007.02596.x.
Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.
Chavan R, Marfatia K, An I, Garber D, Feinberg M
J Virol. 2006; 80(15):7676-87.
PMID: 16840346
PMC: 1563727.
DOI: 10.1128/JVI.02748-05.
Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.
Doherty D, Rosendahl M, Smith D, Hughes J, Chlipala E, Cox G
Bioconjug Chem. 2005; 16(5):1291-8.
PMID: 16173810
PMC: 1373678.
DOI: 10.1021/bc050172r.
Graph-representation of oxidative folding pathways.
Agoston V, Cemazar M, Kajan L, Pongor S
BMC Bioinformatics. 2005; 6:19.
PMID: 15676070
PMC: 549202.
DOI: 10.1186/1471-2105-6-19.
Biological activity of human granulocyte-macrophage colony stimulating factor is maintained in a fusion with seed glutelin peptide.
Sardana R, Alli Z, Dudani A, Tackaberry E, Panahi M, Narayanan M
Transgenic Res. 2002; 11(5):521-31.
PMID: 12437083
DOI: 10.1023/a:1020343501475.
Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
Pettit D, Lawter J, Huang W, Pankey S, Nightlinger N, Lynch D
Pharm Res. 1997; 14(10):1422-30.
PMID: 9358556
DOI: 10.1023/a:1012176823155.
Clinical role of GM-CSF in neutrophil recovery in relation to health care parameters.
Hofstra L, De Vries E, Uyl-de Groot C, Vellenga E
Med Oncol. 1996; 13(3):177-84.
PMID: 9106177
DOI: 10.1007/BF02990845.